Skip to main content
Erschienen in: World Journal of Surgery 11/2007

01.11.2007

Risk Factors for Recurrence to the Lymph Node in Papillary Thyroid Carcinoma Patients without Preoperatively Detectable Lateral Node Metastasis: Validity of Prophylactic Modified Radical Neck Dissection

verfasst von: Yasuhiro Ito, Takuya Higashiyama, Yuuki Takamura, Akihiro Miya, Kaoru Kobayashi, Fumio Matsuzuka, Kanji Kuma, Akira Miyauchi

Erschienen in: World Journal of Surgery | Ausgabe 11/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Although papillary carcinoma usually shows mild characteristics, it metastasizes and shows recurrence to the lymph node in high incidences. Of the two representative lymph node compartments to which papillary carcinoma metastasizes, the central compartment can be routinely dissected via the surgical incision made for thyroidectomy. However, the routine application of prophylactic lateral node dissection (modified radical neck dissection [MND]) remains controversial. In this study, we investigated risk factors for lymph node recurrence of papillary carcinoma to determine the appropriate application of prophylactic MND.

Methods

We investigated risk factors for lymph node recurrence in 1,231 patients without preoperatively detectable lateral node metastasis who underwent thyroidectomy, central node dissection, and prophylactic MND for papillary carcinoma between 1987 and 1995.

Results

The incidence of lateral node metastasis and the number of metastatic lateral nodes significantly increased with carcinoma size. The lymph node disease-free survival (LN-DFS) was also significantly worse in carcinoma with a maximal diameter greater than 3 cm. Massive extrathyroid extension, male gender, and age 55 years or older also reflected a poorer LN-DFS. The 10-year LN-DFS rates of patients with carcinoma having two and three or four of these features were low at 88.5% and 64.7%, respectively, although the rates of those with carcinoma having no or only one characteristic were better than 95%.

Conclusions

Prophylactic MND is recommended for cases of papillary carcinoma demonstrating two or more of the following four characteristics; male gender, age 55 years or older, maximal tumor diameter larger than 3 cm, and massive extrathyroid extension.
Literatur
1.
Zurück zum Zitat Noguchi S, Noguchi A, Murakami N (1970) Papillary carcinoma of the thyroid. I. Developing pattern of metastasis. Cancer 26:1053–1060PubMedCrossRef Noguchi S, Noguchi A, Murakami N (1970) Papillary carcinoma of the thyroid. I. Developing pattern of metastasis. Cancer 26:1053–1060PubMedCrossRef
2.
Zurück zum Zitat Ito Y, Miyauchi A, Jikuzono T, et al. (2007) Risk factors contributing to a poor prognosis of papillary thyroid carcinoma; validity of UICC/AJCC TNM classification and stage grouping. World J Surg 31:838–848PubMedCrossRef Ito Y, Miyauchi A, Jikuzono T, et al. (2007) Risk factors contributing to a poor prognosis of papillary thyroid carcinoma; validity of UICC/AJCC TNM classification and stage grouping. World J Surg 31:838–848PubMedCrossRef
3.
Zurück zum Zitat Kouvaraki MA, Shapiro SE, Bruno MS, et al. (2003) Role of preoperative ultraosonography in the surgical management of patients with thyroid cancer. Surgery 134:946–955 PubMedCrossRef Kouvaraki MA, Shapiro SE, Bruno MS, et al. (2003) Role of preoperative ultraosonography in the surgical management of patients with thyroid cancer. Surgery 134:946–955 PubMedCrossRef
4.
Zurück zum Zitat Stulak JM, Grant CS, Farley DR, et al. (2006) Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid carcinoma. Arch Surg 141:489–496PubMedCrossRef Stulak JM, Grant CS, Farley DR, et al. (2006) Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid carcinoma. Arch Surg 141:489–496PubMedCrossRef
5.
Zurück zum Zitat Dralle H, Gimm O (1996) Lymphadenektomie beim schilddrusencarcinom. Chirurg 67:788–806 (in German)PubMedCrossRef Dralle H, Gimm O (1996) Lymphadenektomie beim schilddrusencarcinom. Chirurg 67:788–806 (in German)PubMedCrossRef
6.
Zurück zum Zitat Martenson H, Terins J (1985) Recurrent laryngeal nerve palsy in thyroid gland surgery related to operations and nerves at risk. Arch Surg 120:475–482 Martenson H, Terins J (1985) Recurrent laryngeal nerve palsy in thyroid gland surgery related to operations and nerves at risk. Arch Surg 120:475–482
7.
Zurück zum Zitat Scheumann GF, Seeliger H, Musholt TF, et al. (1996) Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. Eur J Surg 162:677–684PubMed Scheumann GF, Seeliger H, Musholt TF, et al. (1996) Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. Eur J Surg 162:677–684PubMed
8.
Zurück zum Zitat McConahey WM, Hay ID, Woolner LB, et al. (1986) Papillary thyroid cancer treated at Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy and outcome. Mayo Clin Proc 61:978–996PubMed McConahey WM, Hay ID, Woolner LB, et al. (1986) Papillary thyroid cancer treated at Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy and outcome. Mayo Clin Proc 61:978–996PubMed
9.
Zurück zum Zitat DeGroot LJ, Kaplan EL, McCormick M, et al. (1990) Natural history, treatment, and course of papillary thyroid carcinomas. J Clin Endocrinol Metab 71:414–424PubMedCrossRef DeGroot LJ, Kaplan EL, McCormick M, et al. (1990) Natural history, treatment, and course of papillary thyroid carcinomas. J Clin Endocrinol Metab 71:414–424PubMedCrossRef
10.
Zurück zum Zitat Mazzaferri EL, Young RL (1981) Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 70:511–518PubMedCrossRef Mazzaferri EL, Young RL (1981) Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 70:511–518PubMedCrossRef
11.
Zurück zum Zitat Cunningham MP, Duda RB, Recant W, et al. (1990) Survival discriminants for differentiated thyroid cancer. Am J Surg 160:344–347PubMedCrossRef Cunningham MP, Duda RB, Recant W, et al. (1990) Survival discriminants for differentiated thyroid cancer. Am J Surg 160:344–347PubMedCrossRef
12.
Zurück zum Zitat Bacourt F, Asselain B, Savoie JC, et al. (1986) Multivariate study of prognostic factors in differentiated thyroid carcinoma and re-evaluation of the important of age. Br J Surg 73:274–277PubMedCrossRef Bacourt F, Asselain B, Savoie JC, et al. (1986) Multivariate study of prognostic factors in differentiated thyroid carcinoma and re-evaluation of the important of age. Br J Surg 73:274–277PubMedCrossRef
13.
Zurück zum Zitat Grabe SKG, Hay ID (1996) Thyroid cancer nodal metastasis. Surg Oncol Clin North Am 5:43–63 Grabe SKG, Hay ID (1996) Thyroid cancer nodal metastasis. Surg Oncol Clin North Am 5:43–63
14.
Zurück zum Zitat Sellers M, Beenken S, Blankenship A, et al. (1992) Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer. Am J Surg 164:578–581PubMedCrossRef Sellers M, Beenken S, Blankenship A, et al. (1992) Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer. Am J Surg 164:578–581PubMedCrossRef
16.
Zurück zum Zitat Lungdren CI, Hall P, Dickman PW, et al. (2006) Clinically significant prognostic factors for differentiated thyroid carcinoma. A population-based, nested case-control study. Cancer 106:524–531CrossRef Lungdren CI, Hall P, Dickman PW, et al. (2006) Clinically significant prognostic factors for differentiated thyroid carcinoma. A population-based, nested case-control study. Cancer 106:524–531CrossRef
17.
Zurück zum Zitat Simon D, Goretzki PE, Witte J, et al. (1996) Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg 20:860–866PubMedCrossRef Simon D, Goretzki PE, Witte J, et al. (1996) Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg 20:860–866PubMedCrossRef
18.
Zurück zum Zitat Noguchi S, Murakami N, Yamashita H, et al. (1998) Papillary thyroid carcinoma. Modified radical neck dissection improves prognosis. Arch Surg 133:276–280PubMedCrossRef Noguchi S, Murakami N, Yamashita H, et al. (1998) Papillary thyroid carcinoma. Modified radical neck dissection improves prognosis. Arch Surg 133:276–280PubMedCrossRef
19.
Zurück zum Zitat Sakamoto A, Kasai N, Sugano H (1983) Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 52:1849–1855PubMedCrossRef Sakamoto A, Kasai N, Sugano H (1983) Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 52:1849–1855PubMedCrossRef
20.
Zurück zum Zitat DeLellis RA, Lloyd RV, Heitz PU, et al. (2004) WHO Classification of Tumours, Pathology and Genetics of Tumours of Endocrine Organs. IARC Press, Lyon, France, pp 73–76 DeLellis RA, Lloyd RV, Heitz PU, et al. (2004) WHO Classification of Tumours, Pathology and Genetics of Tumours of Endocrine Organs. IARC Press, Lyon, France, pp 73–76
21.
Zurück zum Zitat Sobin LH, Wittekind Ch (2002) eds. UICC; TNM classification of malignant tumors, 6th Edition. New York, Wiley-Liss Sobin LH, Wittekind Ch (2002) eds. UICC; TNM classification of malignant tumors, 6th Edition. New York, Wiley-Liss
22.
Zurück zum Zitat Antonelli A, Miccoli P, Ferdeghini M, et al. (1995) Role of neck ultrsonography in follow-up of patients operated on for different thyroid cancer. Thyroid 5:25–29PubMedCrossRef Antonelli A, Miccoli P, Ferdeghini M, et al. (1995) Role of neck ultrsonography in follow-up of patients operated on for different thyroid cancer. Thyroid 5:25–29PubMedCrossRef
23.
Zurück zum Zitat Uruno T, Miyauchi A, Shimizu K, et al. (2005) Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer. World J Surg 29:493–495 Uruno T, Miyauchi A, Shimizu K, et al. (2005) Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer. World J Surg 29:493–495
24.
Zurück zum Zitat Miyauchi A, Matsusaka K, Kihara M, et al. (1998) The role of ansa-to-recurrent-laryngeal nerve anastomosis in operations for thyroid cancer. Eur J Surg 164:927–933PubMedCrossRef Miyauchi A, Matsusaka K, Kihara M, et al. (1998) The role of ansa-to-recurrent-laryngeal nerve anastomosis in operations for thyroid cancer. Eur J Surg 164:927–933PubMedCrossRef
25.
Zurück zum Zitat Miyauchi A, Yokozawa T, Kobayashi K, et al. (2001) Opposite ansa cervicalis to recurrent laryngeal nerve anastomosis to restore phonation in patients with advanced thyroid cancer. Eur J Surg 167:540–541PubMedCrossRef Miyauchi A, Yokozawa T, Kobayashi K, et al. (2001) Opposite ansa cervicalis to recurrent laryngeal nerve anastomosis to restore phonation in patients with advanced thyroid cancer. Eur J Surg 167:540–541PubMedCrossRef
26.
Zurück zum Zitat Mazzaferri EL, Young RL, Oertel JE, et al. (1977) Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine 56:171–195PubMedCrossRef Mazzaferri EL, Young RL, Oertel JE, et al. (1977) Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine 56:171–195PubMedCrossRef
27.
Zurück zum Zitat Ito Y, Tomoda C, Uruno T, et al. (2004) Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 28:1115–1121PubMedCrossRef Ito Y, Tomoda C, Uruno T, et al. (2004) Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 28:1115–1121PubMedCrossRef
28.
Zurück zum Zitat Ito Y, Miyauchi A. Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits and risks. World J Surg 31:905–915 Ito Y, Miyauchi A. Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits and risks. World J Surg 31:905–915
29.
Zurück zum Zitat Ito Y, Tomoda C, Uruno T, et al. (2004) Preoperative ultrasonographic examination for lymph node metastasis is useful when designing lymph node dissection for papillary microcarcinoma. World J Surg 28:498–501PubMedCrossRef Ito Y, Tomoda C, Uruno T, et al. (2004) Preoperative ultrasonographic examination for lymph node metastasis is useful when designing lymph node dissection for papillary microcarcinoma. World J Surg 28:498–501PubMedCrossRef
30.
Zurück zum Zitat Simon D, Goretzki PE, Witte J, et al. (1996) Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg 20:860–866PubMedCrossRef Simon D, Goretzki PE, Witte J, et al. (1996) Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg 20:860–866PubMedCrossRef
31.
Zurück zum Zitat Kaupferman ME, Patterson DM, Mandel SJ, et al. (2004) Safety of modified radical neck dissection for differentiated thyroid carcinoma. Laryngoscope 114:403–406CrossRef Kaupferman ME, Patterson DM, Mandel SJ, et al. (2004) Safety of modified radical neck dissection for differentiated thyroid carcinoma. Laryngoscope 114:403–406CrossRef
32.
Zurück zum Zitat Ito Y, Tomoda C, Uruno T, et al. (2006) Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 30:780–786PubMedCrossRef Ito Y, Tomoda C, Uruno T, et al. (2006) Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 30:780–786PubMedCrossRef
Metadaten
Titel
Risk Factors for Recurrence to the Lymph Node in Papillary Thyroid Carcinoma Patients without Preoperatively Detectable Lateral Node Metastasis: Validity of Prophylactic Modified Radical Neck Dissection
verfasst von
Yasuhiro Ito
Takuya Higashiyama
Yuuki Takamura
Akihiro Miya
Kaoru Kobayashi
Fumio Matsuzuka
Kanji Kuma
Akira Miyauchi
Publikationsdatum
01.11.2007
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 11/2007
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-007-9224-y

Weitere Artikel der Ausgabe 11/2007

World Journal of Surgery 11/2007 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.